Parental history of premature coronary heart disease: An independent risk factor of myocardial infarction

Journal of Clinical Epidemiology

Volumn 49, Issue 5, 1996, Pages 497-503

  Jousilahti, Pekka ^a   Puska, Pekka ^a   Vartiainen, Erkki ^a   Pekkanen, Juha ^a   Tuomilehto, Jaakko ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Coronary heart disease; Family history; Myocardial infarction; Parental history; Risk factors

Indexed keywords

ADULT; ANGINA PECTORIS; ARTICLE; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; FAMILY HISTORY; FEMALE; FINLAND; HEART INFARCTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MALE; NORMAL HUMAN; OBESITY; PARENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SMOKING; SOCIAL STATUS;

EID: 0029967332     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/0895-4356(95)00581-1     Document Type: Article

References (44)

1. Rose G. Familial patterns in ischaemic heart disease. Br J Prev Soc Med 1964; 18: 75-80.
2. Friedman GD, Klatsky AI, Siegelaub AB, McCarthy N. Kaiser-Permanente epidemiologic study of myocardial infarction. Study design and results for standard risk factors. Am J Epidemiol 1974; 99: 101-116.
3. Sholtz RI, Rosenman RH, Brand RJ. The relationship of reported parental history to the incidence of coronary heart disease in Western Collaborative Group Study. Am J Epidemiol 1975; 102: 350-356.
4. Thelle DS, Førde OH. The cardiovascular study in Finnmark County: Coronary risk factors and the occurrence of myocardial infarction in first degree relatives and in subjects of different ethnic origin. Am J Epidemiol 1979; 110: 708-715.
5. Rissanen AM. Familial occurrence of coronary heart disease: Effect of the age and at the diagnosis. Am J Cardiol 1979; 44: 60-66.
6. Nora JJ, Lortsher RH, Spangler RD, Nora AH, Kimberling WJ. Genetic epidemiologic study of early onset ischemic heart disease. Circulation 1980; 61: 503-508.
7. Snowden CB, McNamara PM, Garrison RJ, Feinleib M, Kannel WB, Epstein FH. Predicting coronary heart disease in siblings - a multivariate assessment. The Framingham Heart Study. Am J Epidemiol 1982; 115: 217-222.
8. Ten Kate LP, Boman H, Daiger SP, Motulsky AG. Familial aggregation of coronary heart disease and its relation to known genetic risk factors. Am J Cardiol 1982; 50: 945-953.
9. Barret-Connor E, Khaw KT. Family history of heart attack as an independent predictor of death due to cardiovascular disease. Circulation 1984; 69: 1065-1069.
10. Perkins KE. Family history of coronary heart disease: Is it an independent risk factor. Am J Epidemiol 1986; 124: 182-194.
11. Nyboe J, Jensen G, Appleyard M, Schnohr P. Risk factors for acute myocardial infarction in Copenhagen. I. Hereditary, educational and socioeconomic factors. Eur Heart J 1989; 10: 910-916.
12. Schildkraut JM, Myers RH, Cupples LA, Kiely DK, Kannel WB. Coronary risk associated with age and sex of parental heart disease in Framingham Study. Am J Cardiol 1989; 64: 555-559.
13. Myers RH, Kely DK, Cupples LA, Kannel WB. Parental history is an independent risk factor for coronary artery disease: The Framingham Study. Am Heart J 1990; 120: 963-969.
14. Lauer RM. A family history of risk factors and cardiovascular diseases. Circulation 1991; 84: 1445-1446.
15. Colditz GA, Rimm EB, Giovannucci E, Stampfer MJ, Rosner B, Willet WC. A prospective study of parental history of myocardial infarction and coronary artery disease in men. Am J Cardiol 1991; 67: 933-938.
16. Roncaglioni MC, Santoro L, D'Avanzo B, Negri E, Nobili A, Ledda A, Pietropaolo F, Franzosi MG, La Vecchia C, Feruglio GA, Maseri A (on behalf of GISSI-EFRIM Investigators). Role of family history in patients with myocardial infarction. An Italian case-control study. Circulation 1992; 85: 2065-2072.
17. Marenberg ME, Risch N, Berkman LF, Floderus B, de Faire U. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 1994; 330: 1041-1046.
18. Keys A. Coronary heart disease in seven countries. Am Heart Assoc Monogr 1970; 29.
19. Uemura K, Pisa Z. Trends in cardiovascular disease mortality in industrialized countries since 1950. World Health Stat Q 1988, 41: 155-178.
20. Salomaa V, Arstila M, Kaarsalo L, Ketonen M, Kuulasmaa K, Lehto S, Miettinen H, Mustaniemi H, Niemelä M, Palomäki P, Pyörälä K, Torppa J, Tuomilehto J, Vuorenmaa T. Trends in the incidence of and mortality from coronary heart disease in Finland, 1983-1988. Am J Epidemiol 1992; 136: 1303-1315.
21. Kannel WB, Castelli WP, Gordon T, McNamara PM. Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann Intern Med 1971; 74: 1-12.
22. Stamler J. Lifestyles, major risk factors, proof and public policy. Circulation 1978; 58: 3-19.
23. The Pooling Project Research Group. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities no incidence of major coronary events: Final report of the Pooling Project, Dallas. Am Heart Assoc Monogr 1978; 60.
24. Keys A. Seven Countries: A Multivariate Analysis of Death and Coronary Heart Disease. Harvard University Press, Cambridge, 1980.
25. Neaton JD, Wentworth D (for the Multiple Risk Factor Intervention Trial Research Group). Serum cholesterol, blood pressure, cigarette smoking and death from coronary heart disease. Arch Intern Med 1992; 152: 56-64.
26. Pyörälä K, Laakso M, Uusitupa M. Macrovascular disease in diabetes mellitus. An epidemiologic view. Diabetes Metab Rev 1987; 3: 463-542.
27. Pi-Sunyer FX. Medical hazards of obesity. Ann Intern Med 1993; 119: 655-660.
28. Lahelma E, Valkonen T. Health and social inequities in Finland and elsewhere. Soc Sci Med 1990; 31: 257-265.
29. Puska P, Tuomilehto J, Salonen J, Nissinen A, Virtamo J, Björkqvist S, Koskela K, Neittaanmaki L, Takalo T, Kottke TE, Mäki J, Sipilä P, Varvikko P. Community control of cardiovascular disease - the North Karelia Project: Evaluation of a comprehensive community programme for control of cardiovascular diseases in 1972-1977 in North Karelia. WHO/EURO, Copenhagen, 1981.
30. Vartiainen E, Puska P, Jousilahti P, Korhonen HJ, Touomilehto J. Twenty year trends in coronary risk factors in North Karelia and in other areas in Finland. Int J Epidemiol 1994; 23: 495-504.
31. Tuomilehto J, Korhonen HJ, Kartovaara L, Salomaa V, Stengård JH, Pitkänen M, Aro A, Javela K, Uusitupa M, Pitkäniemi J. Prevalence of diabetes mellitus and impaired glucose tolerance in the middle-aged population of three areas in Finland. Int J Epidemiol 1991; 20: 1010-1017.
32. Cox DR, Regression models and life tables. J R Stat Soc B 1972; 34: 187-220.
33. Silberberg JS. Estimating the benefits of cholesterol lowering: Are risk factors for coronary heart disease multiplicative? J Clin Epidemiol 1990; 43: 875-879.
34. SAS Institute, Inc. SAS/STAT User's Guide, version 6, 4th Ed., Vols. 1-2. SAS Institute, Inc., Cary, North Carolina, 1990.
35. Friedman GD, Selby JV, Quesenberry CP Jr, Amstrong MA, Klatsky AL. Precursors of essential hypertension; Body weight, alcohol and salt use, and parental history of hypertension. Prev Med 1988; 17: 387-402.
36. Pekkanen J, Tervahauta M, Nissinen A, Karvonen MJ. Does the predictive value of baseline coronary risk factors change over a 30-year follow-up? Cardiology 1993; 82: 181-190.
37. Pyörälä K, Salonen JT, Valkonen T. Trends in coronary heart disease mortality and morbidity and related factors in Finland. Cardiology 1985; 72: 35-51.
38. Kee F, Tiret L, Robo JY, Nicaud V, McCrum E, Evans A, Cambien F. Reliability of reported family history of myocardial infarction. Br Med J 1993; 307: 1528-1530.
39. NIH Consensus Conference. Triglyceride, high-density lipoprotein and coronary heart disease. JAMA 1993; 269: 505-510.
40. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Atherosclerosis 1988; 8: 1-21.
41. Hamsten A. The hemostatic system and coronary heart disease. Thromb Res 1993; 70: 1-38.
42. Cambien F, Poirier O, Lecerf L, Evans A, Cambou J-P, Arveiler D, Luc G, Bard J-M, Bara L, Ricard S, Tiret L, Amouyel P, Alhenc-Gelas F, Soubrier F. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature (London) 1992; 359: 641-644.
43. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willet WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993; 328: 1450-1456.
44. Barker DJP, Gluckman PD, Godfrey KM, Harding JE, Owens JA, Robinson JS. Fetal nutrition and cardiovascular disease in adult life. Br Med J 1993; 341: 938-941.